{"filing":{"accession_number":"0001104659-26-067509","cik":"0000310158","ticker":"MRK","company_name":"Merck \u0026 Co., Inc.","form":"8-K","filing_date":"2026-05-28","report_date":null,"primary_document":"tm2615833d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/310158/000110465926067509/tm2615833d1_8k.htm"},"events":[{"id":8369,"run_id":7350,"accession_number":"0001104659-26-067509","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from Merck's Annual Meeting of Shareholders held on May 26, 2026, filed under Item 5.07. The filing reports voting outcomes on six matters: election of 13 directors, advisory vote on named executive officer compensation, ratification of the independent auditor, and three shareholder proposals. All proposals passed with majority support, and the detailed vote tallies (votes for, against, abstentions, and broker non-votes) are provided for each matter, which is material to investors' understanding of shareholder governance and company direction.","company_name":"Merck \u0026 Co., Inc.","ticker":"MRK","filing_date":"2026-05-28","form":"8-K","submitted_at":null,"items":[{"id":2234,"accession_number":"0001104659-26-067509","item_number":"5.07","item_title":"Submission of Matters to a Vote","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Merck's Annual Meeting of Shareholders held on May 26, 2026, filed under Item 5.07. The filing reports voting outcomes on six matters: election of 13 directors, advisory vote on named executive officer compensation, ratification of the independent auditor, and three shareholder proposals. All proposals passed with majority support, and the detailed vote tallies (votes for, against, abstentions, and broker non-votes) are provided for each matter, which is material to investors' understanding of shareholder governance and company direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:16:35.959417+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2234,"accession_number":"0001104659-26-067509","item_number":"5.07","item_title":"Submission of Matters to a Vote","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Merck's Annual Meeting of Shareholders held on May 26, 2026, filed under Item 5.07. The filing reports voting outcomes on six matters: election of 13 directors, advisory vote on named executive officer compensation, ratification of the independent auditor, and three shareholder proposals. All proposals passed with majority support, and the detailed vote tallies (votes for, against, abstentions, and broker non-votes) are provided for each matter, which is material to investors' understanding of shareholder governance and company direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:16:35.959417+00:00","company_name":"Merck \u0026 Co., Inc.","ticker":"MRK","filing_date":"2026-05-28"}]}